J and J Snack Foods Newswire (Page 2)

Comprehensive Real-Time News Feed for J and J Snack Foods. (Page 2)

Results 21 - 40 of 595 in J and J Snack Foods

  1. Covidien Again Sues J&J Unit Over Surgical-Tool PatentsRead the original story

    Tuesday Jun 24 | WRKO-AM Brighton

    Covidien said it is again suing a Johnson & Johnson unit in a Connecticut federal court, alleging that an ultrasonic surgical device made by the J&J company infringes on some of Covidien's patents.

    Comment?

  2. Covidien Again Sues J&J Unit Over Surgical-Tool PatentsRead the original story

    Tuesday Jun 24 | Wall Street Journal

    Covidien said Tuesday that it is again suing a Johnson & Johnson unit in a Connecticut federal court, alleging that an ultrasonic surgical device made by the J&J company infringes on some of Covidien's patents.

    Comment?

  3. Johnson & Johnson: Buy The Dip...But Not YetRead the original story

    Tuesday Jun 24 | Seeking Alpha

    J&J hit a new 52-week high last week and the stock is up 20% in the past 4 months.

    Comment?

  4. Fiber optic, fiber schmoptic! We've got the Come to Rotary Dial City Initiative 2014Read the original story w/Photo

    Friday Jun 20 | NA Confidential

    Boy oh boy, the city of New Albany listens! And what elderly Democratic Party voters are telling us is that we don't need no stinking fiber optic network just to build pallets at J & J! Who needs fiber optic, anyway? We have all these old phones stacked up in the back room down at the Street Department! There's just one little problem, so if anyone ... (more)

    Comment?

  5. NAPSR news: J & J and Glaxo (ViiV Healthcare) join forces to develop HIV combo treatmentRead the original story

    Wednesday Jun 18 | PR Log

    Jun. 18, 2014 - WASHINGTON, D.C. -- Johnson & Johnson has signed a deal with Viiv Healthcare to collaborate on a new single tablet that incorporates two anti viral treatments.

    Comment?

  6. Marketing to moms requires unique approachRead the original story w/Photo

    Wednesday Jun 18 | The Charlotte Observer

    This week's "Ask the Mompreneur" features an interview with Samantha Kurtzman-Counter, President and co-founder of The Mother Company, which specializes in safety and social skills media for kids .

    Comment?

  7. J&J Snack Foods Debuts Minute Maid(R) Flavored 100% Juice BarsRead the original story

    Tuesday Jun 17 | Sys-Con Media

    Minute Maid 100% Juice Bars are naturally flavored and made with apple juice from concentrate and added ingredients.

    Comment?

  8. Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & JohnsonRead the original story

    Monday Jun 16 | Benzinga

    Wall Street appeared comfortable with the latest big healthcare merger, this one the acquisition of Covidien by Medtronic , a deal which turns eyes to Johnson & Johnson .

    Comment?

  9. J&J Snack Foods and Snyders-Lance: 2 Snack Companies to WatchRead the original story

    Monday Jun 16 | The Motley Fool

    With that said, plenty of good investment ideas can be found in relatively unknown companies.

    Comment?

  10. J&J: New data shows Invokana reduces blood glucose levelsRead the original story

    Jun 3, 2014 | Theflyonthewall.com

    Viiv Healthcare announces collaboration with Janssen ViiV Healthcare announced that they have entered into an agreement with Janssen R&D Ireland Ltd for the development and commercialisation of a single-tablet combining dolutegravir and Janssen's non-nucleoside reverse transcriptase inhibitor rilpivirine.

    Comment?

  11. 3 Dividend Stocks Fighting for GrowthRead the original story w/Photo

    Saturday Jun 14 | The Motley Fool

    The holy grail of drug development is blockbuster status, the unofficial stamp of commercial success awarded to therapies when their sales eclipse $1 billion annually.

    Comment?

  12. J&J's energy answers are blowing in the wind in Irish collaborationRead the original story w/Photo

    Jun 9, 2014 | In-PharmaTechnologist.com

    J&J says it collaborated with Novartis and GSK to install wind turbines in Cork, Ireland to substantially reduce electricity costs at its local manufacturing plants.

    Comment?

  13. 3 Reasons Johnson & Johnson Is a Great Dividend Stock for New InvestorsRead the original story

    Friday Jun 13 | The Motley Fool

    It's diverse . The consumer and medical device segments combine for about 60% of the company's revenue, which helps balance out the more risky drug-making division.

    Comment?

  14. GSK, J&J develop single-pill HIV medicineRead the original story

    Thursday Jun 12 | The Jersey Journal

    New options that advance current therapies are increasingly important as patients and clinicians consider HIV care over the long term."

    Comment?

  15. J&J links up with GSK-led group on new two-drug HIV tabletRead the original story

    Thursday Jun 12 | Reuters

    Johnson & Johnson has linked up with ViiV Healthcare - a specialist HIV company majority-owned by GlaxoSmithKline - to develop a new AIDS medicine combining two drugs in a single tablet.

    Comment?

  16. TKC Breaking and Exclusive News!!! Slapfight!!! War of Words: Kansas...Read the original story w/Photo

    Tuesday Jun 10 | Tony's Kansas City

    TKC BREAKING AND EXCLUSIVE NEWS!!! SLAPFIGHT!!! WAR OF WORDS: KANSAS CITY LIGHT RAIL BATTLE ROYALE BETWIXT DAVE HELLING VS.

    Comment?

  17. Are Achillion, Inovio Buyout Targets, Like Merck's Idenix?: StockTwitsRead the original story

    Tuesday Jun 10 | TheStreet.com

    The company's "promising portfolio" of hepatitis C treatments was the main driver of the deal, according to Merck's Research Laboratories president.

    Comment?

  18. J&J's energy answers are blowing in the wind in Irish collaborationRead the original story w/Photo

    Jun 9, 2014 | In-PharmaTechnologist.com

    J&J says it collaborated with Novartis and GSK to install wind turbines in Cork, Ireland to substantially reduce electricity costs at its local manufacturing plants.

    Comment?

  19. Complex manufacturing more likely kept in-house, says J&J post Ben VenueRead the original story w/Photo

    Jun 5, 2014 | Drug Researcher

    Outsourcing is still a significant part of Janssen's strategy, the firm says despite suffering shortages due to manufacturing and quality problems at now defunct CMO Ben Venue.

    Comment?

  20. Research and Markets: Global Protein Therapeutics Market 2012-2016:...Read the original story

    Jun 9, 2014 | Business Wire

    The analysts forecast the Global Protein Therapeutics market to grow at a CAGR of 7.08 percent over the period 2012-2016.

    Comment?